1. Home
  2. Analysis
  3. Stelara
  4. Invega

Stelara and Invega drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Stelara (ustekinumab) and Invega (paliperidone). Common drug interactions include memory impairment among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Stelara and Invega. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.

What is Invega?

Invega has active ingredients of paliperidone. It is often used in bipolar disorder. eHealthMe is studying from 32,353 Invega users. Check the latest studies of Invega.

On Jul, 14, 2026

14 people who take Stelara and Invega together, and have interactions are studied.

Stelara and Invega drug interactions.

What are the common drug interactions of Stelara and Invega, by gender? *:

female:

  1. Memory impairment
  2. Overdose
  3. Suicidal ideation
  4. Therapeutic response unexpected
  5. Weight decreased
  6. Rash
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Weight increased
  9. Blood glucose decreased
  10. Cough

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Pancreatic disorder

What are the common drug interactions of Stelara and Invega, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypoglycaemia (deficiency of glucose in the bloodstream)
  2. Rash
  3. Weight increased

40-49:

  1. Rash
  2. Blood glucose decreased
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Weight increased

50-59:

n/a

60+:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 42.86%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 42.86%
  3. Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 2 people, 14.29%
  4. Hypoglycemia (low blood sugar): 2 people, 14.29%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.14%
  6. Depression: 1 person, 7.14%
  7. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Stelara and Invega?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Stelara and Invega:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Invega:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stelara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invega and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ustekinumab and paliperidone (the active ingredients of Stelara and Invega, respectively), and Stelara and Invega (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.